scispace - formally typeset
L

Lei Zhang

Researcher at Central South University

Publications -  694
Citations -  15023

Lei Zhang is an academic researcher from Central South University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 51, co-authored 588 publications receiving 11345 citations. Previous affiliations of Lei Zhang include Monash University & Kirby Institute.

Papers
More filters
Journal ArticleDOI

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.

Goodarz Danaei, +340 more
TL;DR: In this paper, the authors used data for exposure to risk factors by country, age group, and sex from pooled analyses of population-based health surveys and obtained relative risks for the eff ects of risk factors on cause-specifi c mortality from meta-analyses of large prospective studies.
Journal ArticleDOI

Broadband polarization-independent perfect absorber using a phase-change metamaterial at visible frequencies.

TL;DR: The proposed phase-change metamaterial provides a simple way to realize a broadband perfect absorber in the visible and near-infrared (NIR) regions and is important for a number of applications including thermally controlled photonic devices, solar energy conversion and optical data storage.
Journal ArticleDOI

HIV prevalence in China: integration of surveillance data and a systematic review.

TL;DR: HIV epidemics among injecting drug users are decreasing in all regions outside southwest China and have stabilised at a high level in northwest China, and strong associations between HIV prevalence among at-risk populations in each province are recorded, supporting the existence of overlap in risk behaviours and mixing among these populations.
Journal ArticleDOI

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models

Jeffrey W. Eaton, +59 more
TL;DR: Estimates suggest that earlier eligibility for antiretroviral therapy is very cost effective in low-income and middle-income settings, although these estimates should be revisited when more data become available.